Cargando…
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
SARS-CoV-2 Spike protein is critical for virus infection via engagement of ACE2, and amino acid variation in Spike is increasingly appreciated. Given both vaccines and therapeutics are designed around Wuhan-1 Spike, this raises the theoretical possibility of virus escape, particularly in immunocompr...
Autores principales: | Kemp, SA, Collier, DA, Datir, R, Ferreira, IATM, Gayed, S, Jahun, A, Hosmillo, M, Rees-Spear, C, Mlcochova, P, Lumb, Ines Ushiro, Roberts, David J, Chandra, Anita, Temperton, N, Sharrocks, K, Blane, E, Briggs, JAG, van, Gils MJ, Smith, KGC, Bradley, JR, Smith, C, Doffinger, R, Ceron-Gutierrez, L, Barcenas-Morales, G, Pollock, DD, Goldstein, RA, Smielewska, A, Skittrall, JP, Gouliouris, T, Goodfellow, IG, Gkrania-Klotsas, E, Illingworth, CJR, McCoy, LE, Gupta, RK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781345/ https://www.ncbi.nlm.nih.gov/pubmed/33398302 http://dx.doi.org/10.1101/2020.12.05.20241927 |
Ejemplares similares
-
SARS-CoV-2 evolution during treatment of chronic infection
por: Kemp, Steven A, et al.
Publicado: (2021) -
Author Correction: SARS-CoV-2 evolution during treatment of chronic infection
por: Kemp, Steven A., et al.
Publicado: (2022) -
Applying prospective genomic surveillance to support investigation of hospital-onset COVID-19
por: Hamilton, William L, et al.
Publicado: (2021) -
Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection?
por: Kacar, Mark, et al.
Publicado: (2021) -
Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency(1)
por: Ugrinovic, S., et al.
Publicado: (2020)